 |
 |
 |
|
Diabetic retinopathy screening made SIMPLE and AFFORDABLE for primary care.
The RetinaVue Network is designed for healthcare providers who want to improve management of patients with diabetes. RetinaVue enables providers to easily perform retinal exams in a primary care setting using a simple four-step process:
(1) acquire non-mydriatic fundus images in minutes with the simple, automated Welch Allyn RetinaVue 100 Imager,
(2) transfer images via secure HIPAA-compliant RetinaVue Network,
(3) images are evaluated by a board-certified retinal specialist, and
(4) a diagnostic report and referral/screening plan is returned to the provider the same day�usually in 90 minutes.
Simple, affordable and effective�now you can easily and accurately screen for diabetic retinopathy as part of a patient�s routine visit.
What's Included:
Welch Allyn RetinaVue 100 Imager with Charging Dock, Reusable Eye Cup, USB Cable, and One Year Comprehensive Partnership; Lithium-Ion 3.6V Battery; 1st Year Partners in Care Comprehensive Program
Note: Diagnostic interpretation services are a necessary component of the RetinaVue solution and are contracted directly with RetinaVue P.C.
Diabetic retinopathy is the leading cause of blindness among working-age adults.
Welch Allyn RetinaVue Network Product Demonstration
|
|
|
 |
|
 |
|
|
|
 |
|
 |
|
Features
- Double HEDIS/STARS compliance rates for diabetic retinal assessment in 12 months
- Most top healthcare plans now reimburse for retinal screenings
- Simple four-step process is effective and affordable
- Same day diagnostic report�usually in 90 minutes
- Like adding a retinal specialist to your team
|
|
|
|
|
|
|